This high-throughput NGS assay enables labs to detect SARS-CoV-2 mutations to identify and track the emergence and prevalence of novel variants.
This product is available for Research Use Only (RUO). An in vitro diagnostic version of this product is available for use in Japan, Philippines, and the US under each country's respective authorizing agency.
COVIDSeq Test (RUO Version) is a next-generation sequencing (NGS) assay that enables researchers to detect and characterize novel variants of SARS-CoV-2.
The Illumina COVIDSeq Test (RUO version) accommodates 384 to 3072 samples, depending on throughput needs.
Coverage is particularly focused on the spike protein locus. For detailed sequencing, the optional ARTIC v4 primer pool provides in-depth characterization of new variants.
The kit includes all reagents needed for cDNA conversion, amplification, and library prep. A 63°C annealing temperature during PCR improves variant analysis and insights.
Assess lineage and annotate mutations with open software tools, including the Illumina DRAGEN COVID Lineage App in BaseSpace Sequence Hub.
| Automation capability | Liquid Handling Robots |
|---|---|
| Automation details | Explore available automation methods |
| Content specifications |
Uniform viral genome coverage across the spike protein locus |
| Description |
The COVIDSeq Test (RUO Version) is a scalable high-throughput NGS assay (up to 3072 samples) intended for research applications. |
| Instruments | MiSeq System, iSeq 100 System, NextSeq 550 System, NextSeq 2000 System, NextSeq 1000 System, MiSeqDx in Research Mode, MiniSeq System, NextSeq 550Dx in Research Mode, NovaSeq 6000Dx in Research Mode, NextSeq 500 System, NovaSeq 6000 System |
| Method | Targeted RNA Sequencing, Amplicon Sequencing |
| Multiplexing |
384-plex on NextSeq 384-plex on NovaSeq |
| Nucleic acid type | RNA |
| Sample type details |
Nasopharyngeal, oropharyngeal, and mid-turbinate nasal swab samples |
| Species category | Human, Virus |
| Species details | SARS-CoV-2 (SARS-CoV-2_ MN908947v3) |
| Strand specificity | Non-Stranded |
| Technology | Sequencing |
In addition to the Illumina COVIDSeq Test (3072 samples), you will need:
IDT for Illumina PCR Indexes Sets 1–4 (384 Indexes, 384 samples)
Flow cell for your sequencing system
Sequencing reagent kit for your sequencing system
Viral RNA extraction kit (eg, QIAamp Viral RNA Mini Kit)
The COVIDSeq Test (RUO Version) is an integrated NGS research solution for detection and characterization of SARS-CoV-2, not for use in diagnostic procedures or patient management.
Illumina COVIDSeq Test (RUO Version)
NGS can identify novel coronavirus variants, track COVID-19 transmission, and more. Compare NGS methods for various coronavirus sequencing goals.
As a hypothesis-free method, NGS can distinguish between infectious disease strains that differ by as little as one SNP, and replace the need for multiple tests.
Host genetics and immune response profiling
Studying host genetic differences and individual immune responses to the SARS-CoV-2 virus can shed light on COVID-19 disease susceptibility and severity.
| COVIDSeq Test (RUO Version) | COVIDSeq Assay (96 samples) | Pan-Coronavirus Panel | Respiratory Pathogen ID/AMR Enrichment Panel Kit |
|---|
Library Prep and Array Kit Selector
Find the right sequencing library preparation kit or microarray for your needs. Filter by method, species, and more. Compare, share, and order kits.
Heat map plotting performance as a function of read length and depth shows significant improvement with paired-end reads over single reads. The fraction of genomes > 0.99 confident is shown, with values close to 1 representing more complete coverage of the SARS-CoV-2 genome.
The COVIDSeq Test (RUO Version) is intended for the NovaSeq 6000 Sequencing System. It can also be run on the iSeq 100, MiniSeq, MiSeq, MiSeqDx in Research Mode, NextSeq 500, NextSeq 550, NextSeq 550Dx in Research Mode, NextSeq 1000, or NextSeq 2000 Systems.
The primary difference is the number of samples each assay can run. The COVIDSeq Assay (96 samples) runs 96 samples on Illumina benchtop sequencing systems to accommodate smaller research labs. In contrast, the COVIDSeq Test (RUO) runs up to 3072 samples on the NovaSeq 6000 System or NextSeq line of sequencing systems.
Yes, an in vitro diagnostic (IVD) test is available for use in authorized countries (Japan, Philippines, and the US) under each country’s respective authorizing agency.
The ARTIC v3 primer pool is included with the COVIDSeq Test (RUO) kit. It contains primers for 98 amplicons and 11 human genes, designed against the original strain of SARS-CoV-2. The optional ARTIC v4 pool includes 99 amplicons and no human controls, designed against the Delta variant. It delivers improved genomic coverage across the spike protein locus and better analytical sensitivity for SARS-CoV-2 variant detection. Read technical note.
Advanced chemistry, optics, and informatics combine to deliver exceptional speed and data quality, outstanding throughput and scalability.
Optimized reagent kit that provides increased cluster density and read length, improving sequencing quality scores compared to earlier versions.
Enable CGP with a large pan-cancer panel covering all major variant classes plus gene signatures (TMB, MSI, and HRD) from FFPE tissue.
A fast, integrated workflow for preparing libraries for use in a wide range of sequencing applications.
This low- to mid-throughput NGS assay enables labs of any size to identify and track the emergence and prevalence of novel SARS-CoV-2 variants.
Library prep and enrichment kit that delivers highly sensitive, comprehensive respiratory pathogen identification and antimicrobial resistance insights.
This panel supports characterization and genomic surveillance of 225 known and novel coronaviruses from humans and animal reservoirs.
Interested in bringing the Illumina COVIDSeq Test into your lab for surveillance applications?
Your email address is never shared with third parties.
